ResearcherStony Brook UniversityActive in the last 2 years
Lyanne Delgado Coka
Matched on ORCID iD 0009-0007-7662-2817; OpenAlex author ID A5116777090. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2024: 2 papers · 2025: 1 paper · 2026: 5 papers
Papers 8
- Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer. First author DOI 10.1002/1878-0261.70218↗
- Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-4534↗
- A KRT17/GATA6 hybrid state marks unique vulnerability to MYC in pancreatic cancer Co-author DOI 10.21203/rs.3.rs-11519779/v1↗
- Continuous tissue fields organize immune composition in pancreatic cancer Co-author DOI 10.64898/2026.08.22.746444↗
- Keratin 17 Defines an Epithelial-Mesenchymal Transition-Associated Migratory Cell State in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.64898/2026.10.27.762113↗
- Advancing Precision Medicine in PDAC: An Ethical Scoping Review and Call to Action for IHC Implementation. Co-author DOI 10.3390/cancers17121899↗
- Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/ajcp/aqae038↗
- Keratin 17 modulates the immune topography of pancreatic cancer. Co-author DOI 10.1186/s12967-024-05252-1↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kenneth Reed Shroyer · 8 shared papers, 2024–2026 · strength 1.90
- Paper Advancing Precision Medicine in PDAC: An Ethical Scoping Review and Call to Action for IHC Implementation. DOI 10.3390/cancers17121899↗
- Paper Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer. DOI 10.1002/1878-0261.70218↗
- Paper Continuous tissue fields organize immune composition in pancreatic cancer DOI 10.64898/2026.08.22.746444↗
- Luisa F. Escobar‐Hoyos · 7 shared papers, 2024–2026 · strength 1.64
- Paper Advancing Precision Medicine in PDAC: An Ethical Scoping Review and Call to Action for IHC Implementation. DOI 10.3390/cancers17121899↗
- Paper Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer. DOI 10.1002/1878-0261.70218↗
- Paper Continuous tissue fields organize immune composition in pancreatic cancer DOI 10.64898/2026.08.22.746444↗
- Scott Powers · 4 shared papers, 2026 · strength 1.03
- Paper Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer. DOI 10.1002/1878-0261.70218↗
- Paper Continuous tissue fields organize immune composition in pancreatic cancer DOI 10.64898/2026.08.22.746444↗
- Paper Keratin 17 Defines an Epithelial-Mesenchymal Transition-Associated Migratory Cell State in Pancreatic Ductal Adenocarci… DOI 10.64898/2026.10.27.762113↗
- Lucia Roa‐Peña · 4 shared papers, 2024–2026 · strength 0.87
- Paper Advancing Precision Medicine in PDAC: An Ethical Scoping Review and Call to Action for IHC Implementation. DOI 10.3390/cancers17121899↗
- Paper Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4534↗
- Paper Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. DOI 10.1093/ajcp/aqae038↗
- Shayan Sarkar · 3 shared papers, 2026 · strength 0.75
- Paper Continuous tissue fields organize immune composition in pancreatic cancer DOI 10.64898/2026.08.22.746444↗
- Paper Keratin 17 Defines an Epithelial-Mesenchymal Transition-Associated Migratory Cell State in Pancreatic Ductal Adenocarci… DOI 10.64898/2026.10.27.762113↗
- Paper Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. DOI 10.1158/0008-5472.can-25-4534↗
- Emanuel F. Petricoin · 2 shared papers, 2024 · strength 0.33
- Andrew Eugene Hendifar · 2 shared papers, 2024 · strength 0.33
- Brent K. Larson · 2 shared papers, 2024 · strength 0.33
- Wei Jiang · 2 shared papers, 2024 · strength 0.33
- Lynn McCormick Matrisian · 2 shared papers, 2024 · strength 0.33
- Brian Nelson · 1 shared paper, 2026 · strength 0.29
- Mikala Egeblad · 1 shared paper, 2026 · strength 0.27
- Weihao Wang · 1 shared paper, 2026 · strength 0.27
- Marie C. Hasselluhn · 1 shared paper, 2026 · strength 0.27
- Mara H. Sherman · 1 shared paper, 2026 · strength 0.27
- Despina Siolas · 1 shared paper, 2026 · strength 0.27
- Emanuel F. Petricoin · 1 shared paper, 2026 · strength 0.21
- Chun‐Hao Pan · 1 shared paper, 2026 · strength 0.21
- Nina V. Chaika · 1 shared paper, 2026 · strength 0.21
- Pankaj Kumar Singh · 1 shared paper, 2026 · strength 0.21
- David Arthur Tuveson · 1 shared paper, 2026 · strength 0.21
- Minsig Choi · 1 shared paper, 2024 · strength 0.17
- Vincent J. Picozzi · 1 shared paper, 2024 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.